TSN and cancer: It has recently been proposed that Translin and Trax may provide anti-cancer therapeutic targets [34]; however, before small molecule inhibitors are developed and applied to the clinical setting it is of fundamental importance that we fully elucidate the normal function of this protein pair to ensure that inhibition of their function does not adversely influence non-diseased tissues.